Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06083909 · ClinicalTrials.gov registry record
Sarcopenic Obesity in the Elderly
A clinical trial, sponsored by University of Central Florida.
- Completed
- Registry status
- 97
- Enrollment target
NCT06083909 is a clinical trial that has completed, run by University of Central Florida. The registered enrollment target is 97 participants.
The verdict
NCT06083909 has completed, sponsored by University of Central Florida.
- COMPLETED
- Registry status
- 97 participants
- Enrollment target
Study Summary
Ageing is associated with progressive and generalized loss of muscle mass and muscle function, also known as Sarcopenia. Increasingly, obesity has become a compounding factor in ageing-related sarcopenia. The coexistence of obesity and sarcopenia is termed sarcopenic obesity (SO). Older adults with SO are at higher risks of developing diabetes, hypertension, stroke, cardiovascular diseases, and cognitive dysfunction than those older adults who suffer from sarcopenia alone or obesity alone. However, there is insufficient information with regard to the interplay between obesity and sarcopenia. The primary objective of this study is to investigate the impact of SO on insulin resistance in people aged 65-85. Our hypothesis is that SO positively influences insulin resistance in the elderly. We propose to investigate sarcopenia and obesity as risk factors for insulin resistance in the geriatric (65-85 years old) population.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2022-04-06 |
| Est. Completion | 2023-05-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06083909
The ClinicalTrials.gov registry entry for NCT06083909 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Central Florida, which has 91 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT06083909 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06083909 about?
NCT06083909 is a clinical study titled "Sarcopenic Obesity in the Elderly". Ageing is associated with progressive and generalized loss of muscle mass and muscle function, also known as Sarcopenia. Increasingly, obesity has become a compounding factor in ageing-related sarcopenia. The coexistence of obesity and sarcopenia is termed sarcopenic obesity (SO). Older adults with ...
What is the current status of trial NCT06083909?
This trial is currently completed. The enrollment target is 97 participants. The study started on 2022-04-06. Estimated completion is 2023-05-08.
Who is sponsoring clinical trial NCT06083909?
This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.